RGD Reference Report - Polymorphisms and vascular cognitive impairment after ischemic stroke. - Rat Genome Database
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Polymorphisms and vascular cognitive impairment after ischemic stroke.

Authors: Baum, L  Chen, X  Cheung, WS  Cheung, CK  Cheung, LW  Chiu, KF  Wen, HM  Poon, P  Woo, KS  Ng, HK  Wong, KS 
Citation: Baum L, etal., J Geriatr Psychiatry Neurol. 2007 Jun;20(2):93-9.
RGD ID: 10402374
Pubmed: (View Article at PubMed) PMID:17548779
DOI: Full-text: DOI:10.1177/0891988706298627

Environmental and genetic factors may both affect the risk of vascular cognitive impairment developing after a stroke. To identify factors affecting this risk, the cognitive status of 121 patients was examined 3 months after an ischemic stroke. In all patients and in 270 control subjects, 7 polymorphisms reported to affect risk of vascular ischemic disease were genotyped. In 51 patients (42.1%), vascular cognitive impairment resulted, defined by a Mini-Mental State Examination score of less than 24. These patients were older and more likely to be women. Alleles of none of the polymorphisms differed between patients with or without vascular cognitive impairment, except for glutamate-cysteine ligase modifier (GCLM) (odds ratio = 2.8, P = .006). When all stroke patients were considered, the GCLM genotype did not affect Mini-Mental State Examination scores. Testing the GCLM genotype in an independent group of stroke patients may determine whether this association with vascular cognitive impairment is genuine.

Annotation

Disease Annotations    
vascular dementia  (IAGP,ISO)

Objects Annotated

Genes (Rattus norvegicus)
Gclm  (glutamate cysteine ligase, modifier subunit)

Genes (Mus musculus)
Gclm  (glutamate-cysteine ligase, modifier subunit)

Genes (Homo sapiens)
GCLM  (glutamate-cysteine ligase modifier subunit)


Additional Information